Thursday, 1 September 2016

Matang gets Bursa nod to list on ACE Market

 Stocks Signals | Multi Management & Future Solutions

Plantation organization Matang Bhd has gotten Bursa Malaysia Securities' endorsement to list on the ACE Market, likely by first quarter of 2017.

The underlying open offer (IPO) will include the issuance of 130 million new shares of 10 sen each in Matang, or 7.18% of the expanded issued and paid-up offer capital.

Matang director Datuk Teh Kean Ming said the endorsement for the posting was a critical turning point in Matang's adventure to end up a recorded substance.

"The IPO will empower us to take advantage of the value capital business sector to raise supports and to give us the money related adaptability to seek after our future development open doors. We anticipate finishing the activity by first quarter 2017," he included.

Stores raised from the IPO would be principally utilized for general working cash-flow to back Matang and its auxiliaries everyday operations.

Part of the returns would be utilized for replanting as Matang tries to enhance the age profile of its oil palm trees, capital use and to settle evaluated posting costs.

As at December 2015, around 32.8 hectares, or 3.0% of Matang's aggregate oil palm manor territory has achieved 21 years or more, which is past its top generation age.

In that capacity, the Group focuses to replant 16.4 hectares of the ranch region every year for 2016 and 2017.

M&A Securities Sdn Bhd is the consultant, supporter and guarantor for the IPO exercise.

Matang was joined on April 28, 2015 as a unique reason vehicle to empower the posting of Matang.

Matang's center exercises are the administration of manor domain, offer of new organic product bundles and property venture holding.

Its Matang bequest contains 45 adjoining bits of horticultural grounds in Ledang and Segamat and spreads 1,096.3 hectares.

For More Updates : - Equity Picks | Stock Tips | Stock Picks | Share Investment | Stock Signals | Stock Investment | Stock signals

No comments:

Post a Comment